Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Via Benzinga
Exposures Product Safety
Tickers ABBV ALVO JNJ REGN
Capricor Therapeutics Stock Tumbles After FDA Confirms Intent To Hold Advisory Committee Meet For Deramiocel Approval: But Retail’s Optimistic
Via Stocktwits
Topics Economy Government
Exposures Economy Political Product Safety
Tickers CAPR VTI XBI
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers NRXP
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints CEO Robert Eno to Board of Directors
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT BMWYY
ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug
Via Benzinga
Exposures Product Safety
Tickers IBRX
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
Via Benzinga
Exposures Product Safety
Tickers LTRN
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter
Via Stocktwits
Topics Intellectual Property Law Enforcement Lawsuit
Exposures Financial Intellectual Property Legal
Tickers CVS NRXP RSLS
Semaglutide Weight Loss Injections: Online Prescription, Home Delivery Launched
Via Press Release Distribution Service
Exposures Product Safety
ICUI SHAREHOLDER ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers ICUI
ICUI SHAREHOLDER ALERT: Kaplan Fox &amp; Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers ICUI
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
Via The Motley Fool
Exposures Product Safety
Tickers MDT
Author’s new book “Patricia Cameron” receives a warm literary welcome.
Via Get News
Topics Product Recall
Exposures Legal Product Safety
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
Via Benzinga
Exposures Product Safety
Tickers BMY CYTK
Trulawn Restores Lawns to Pristine Condition with Unparalleled Expertise and Customer Care in Lynden, WA
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
Revolutionizing Back Pain Treatment: Patient's Journey Highlights Success of PRP Injections at Nourish House Calls
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
Polestar Recalls Nearly 28,000 Vehicles In US Over Faulty Rear Camera Image Display: Retail’s Disappointed
Via Stocktwits
Topics Government Product Recall World Trade
Exposures Legal Political Product Safety
Tickers IEFA PSNY SCZ
Is Novo Nordisk Stock a Buy?
Via The Motley Fool
Exposures Product Safety
Tickers LLY NVO VKTX
Elon Musk Says Neuralink Will 'Ultimately' Be Available To All As FDA Grants Breakthrough Status For Speech-Restoring Brain Tech
Via Benzinga
Exposures Product Safety
Retail Interest in Phathom Soars As Firm Pledges Profit Path, Cuts Costs After Q1 Miss
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers PHAT
ICU MEDICAL ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers ICUI
ICU MEDICAL ALERT: Kaplan Fox &amp; Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers ICUI
DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations
Via StockStory
Exposures Product Safety
Tickers DXCM
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
Via Benzinga
Exposures Product Safety
Tickers MRNA
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Granted FDA Waiver for $4.3 Million NDA Filing Fee for NRX-100
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
United Health Products Announces OTCQB Uplisting and FDA Update
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Tickers UEEC
United Health Products Announces OTCQB Uplisting and FDA Update
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Tickers UEEC
Elkhart, IN Author Publishes Philosophical Poetry Book
Via PR Leap
Topics Product Recall
Exposures Legal Product Safety
Q32 Bio Stock Turns Retail Trader Heads After FDA Grants Fast Track For Alopecia Drug
Via Stocktwits
Topics Stocks
Exposures Product Safety US Equities
Tickers QTTB
Where Is Hims & Hers Stock Headed After Wegovy Tie-Up? Retail Traders Bet On Rebound To Over 2-Month High
Via Stocktwits
Exposures Product Safety
Tickers HIMS LLY NVO
$4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Promising Treatment Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Exposures Product Safety
Tickers NRXP
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.